Christy Jones's most recent trade in Beta Bionics Inc. was a trade of 1,406 Common Stock done at an average price of $15 . Disclosure was reported to the exchange on June 24, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Beta Bionics Inc | Christy Jones | Director | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 24 Jun 2026 | 1,406 | 25,994 | - | 15 | 21,090 | Common Stock |
| Beta Bionics Inc | Christy Jones | Director | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 04 Jun 2026 | 2,811 | 27,400 | - | 14 | 39,354 | Common Stock |
| Beta Bionics Inc | Christy Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 16,965 | 30,211 | - | 0 | Common Stock | |
| Beta Bionics Inc | Christy Jones | Director | Sale of securities on an exchange or to another person at price $ 9.95 per share. | 21 May 2026 | 1,998 | 13,246 | - | 9.9 | 19,880 | Common Stock |
| Beta Bionics Inc | Christy Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2026 | 3,997 | 15,244 | - | 0 | Common Stock | |
| Beta Bionics Inc | Christy Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 11,247 | 11,247 | - | 0 | Common Stock | |
| Beta Bionics Inc | Christy Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 48,730 | 48,730 | - | - | Director Stock Option (right to buy) | |
| Beta Bionics Inc | Christy Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 9,137 | 9,137 | - | - | Director Stock Option (right to buy) | |
| Beta Bionics Inc | Christy Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 9,137 | 9,137 | - | - | Director Stock Option (right to buy) |